Ga naar de content
Terug naar resultaten
Zorggebruik Deelname aan preventieve zorg en screening (Wetenschappelijk) artikel

Availability and accessibility of HIV self-tests and self-sample kits at community pharmacies in the Netherlands

Abstract

Background In 2016 the WHO declared HIV self-testing and self-sampling an effective and safe test option that can reduce testing barriers. HIV self-tests and self-sampling kits (HIVST/HIVSS) are available for purchase at Dutch community pharmacies since 2019. We investigated the availability and accessibility of HIVST/HIVSS in community pharmacies, and factors associated with test availability. Methods An online survey among all Dutch community pharmacies (n = 1,987) was conducted between April and June 2021. Availability of HIVST/HIVSS and experiences of pharmacists with the test offer were analyzed with descriptive statistics. The association of pharmacy and pharmacists’ characteristics with HIVST/HIVSS availability was explored by logistic regression analysis. Results In total, 465 pharmacists completed the questionnaire. Of the responding pharmacists, 6.2% (n = 29) offered HIVST/HIVSS. The majority (82.8%) sold between 0 and 20 tests per year. In total, pharmacies sold an estimated 370 HIVST/HIVSS per year. Pharmacies having HIVST/HIVSS available were less often located in moderately-urbanized to rural neighborhoods (OR 0.35, 95%CI 0.16–0.77 versus highly-urbanized), and were less often located in moderateto-low SES neighborhoods (OR 0.40, 95%CI 0.18–0.88 versus high-SES). Reasons for not offering HIVST/HIVSS by pharmacists were no or little demand (69.3%), and not being familiar with these tests (17.4%). 52% of the pharmacists provided information about testing to test buyers. Reported options to improve the test offer were giving advice about (performing) the test to test buyers (72.4%), placing tests visible on the counter (51.7%), and advertisement (37.9%). Conclusion HIVST/HIVSS have a limited practical availability in Dutch community pharmacies since their introduction in 2019, especially in lower-urbanized and lower-SES areas. Further research is needed to explore how to expand access to HIVST/HIVSS through community pharmacies in the Netherlands, and how to tailor it to the needs of pharmacy clients.

Recent toegevoegd

  • Alle artikelen

    Heb je tijd om een paar korte vragen te beantwoorden?

    De antwoorden worden gebruikt om de Kennishub te evalueren. Door de vragenlijst in te vullen geef je toestemming om je antwoorden te gebruiken voor wetenschappelijk onderzoek.

    This field is for validation purposes and should be left unchanged.
    Bij wat voor organisatie werk je?

    Wat is je functie?

    Wat is de reden voor je bezoek aan deze Kennishub?

    Met het invullen van je e-mailadres geef je toestemming om dit e-mailadres te verwerken en je te mogen benaderen voor een interview. Lees de privacyverklaring voor meer informatie over het verwerken van gegevens. Voor vragen kun je contact opnemen met Marente Mol (marente.mol@rivm.nl).